WallStreetZenWallStreetZen

NASDAQ: BGLC
Bionexus Gene Lab Corp Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Bionexus Gene Lab earnings were -$1.6M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest BGLC earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$348.3k, down 74.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BGLC reported annual earnings of -$1.6M, with -39.2% growth.

BGLC earnings history

Current Revenue
$9.5M
Current Earnings
-$1.6M
Current Profit Margin
-16.8%

BGLC Return on Equity

Current Company
-17.5%
Current Industry
22.1%
Current Market
34.1%
BGLC's Return on Equity (-17.5%)... subscribe to Premium to read more.
High Return on Equity Performance

BGLC undefined

Current Company
-14.6%
Current Industry
7.1%
BGLC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BGLC announces earnings.

BGLC undefined

Current Company
-18.55%
Current Industry
13%
BGLC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BGLC vs Specialty Chemical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BGLC-$1.42M-$1.60MN/A-$0.90
SNES-$6.01M-$6.18MN/A-$8.86
CNEY-$11.31M-$14.04MN/A-$4.13
FEAM-$46.71M-$69.15MN/A-$25.07
SDST-$23.70M-$23.75MN/A-$0.55
View Top Specialty Chemical Stocks

Bionexus Gene Lab Earnings Reports & History FAQ

What were Bionexus Gene Lab's earnings last quarter?

Bionexus Gene Lab (NASDAQ: BGLC) reported Q4 2024 earnings per share (EPS) of -$0.67, up 228.85% year over year. Total BGLC earnings for the quarter were -$348.32 thousand. In the same quarter last year, Bionexus Gene Lab's earnings per share (EPS) was $0.52.

If you're new to stock investing, here's how to buy Bionexus Gene Lab stock.

Is Bionexus Gene Lab profitable or losing money?

As of the last Bionexus Gene Lab earnings report, Bionexus Gene Lab is currently losing money. Bionexus Gene Lab's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$1.60 million, a 39.2% decrease year over year.

What was BGLC's earnings growth in the past year?

As of Bionexus Gene Lab's earnings date in Q2 2025, Bionexus Gene Lab's earnings has grown year over year. BGLC earnings in the past year totalled -$1.60 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.